#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neurodermatitis Chronic lymphocytic leukaemia recurrent Methylmalonic acidaemia Congenital nephrogenic diabetes insipidus Anaplastic thyroid cancer Adenovirus infection Synovitis Scleroderma associated digital ulcer Deafness bilateral High-grade B-cell lymphoma Thalassaemia Alveolar proteinosis Malignant fibrous histiocytoma Fragile X syndrome Neonatal asphyxia More trials…

    Learn about Rare Diseases

    Testicular leiomyosarcoma – Life with Disease Familial amyotrophic lateral sclerosis – Diagnostics Hypereosinophilic syndrome – Diagnostics Short-bowel syndrome – Basic Information Familial amyotrophic lateral sclerosis – Treatment Antithrombin III deficiency – Diagnostics Burkitt’s lymphoma – Treatment Hyperoxaluria CADASIL – Treatment Systemic sclerosis pulmonary More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vidofludimus Calcium Dapirolizumab Pegol Cabozantinib ATUMELNANT Ferrous Sulfate Oleclumab Sodium Hypochlorite INOBRODIB Av-Ec2023 Sufentanil Vx-522 CAL101 Vanzacaftor Interleukin-1 Wt1 Mrna Dc ULEFNERSEN Tinengotinib Retifanlimab Ammonium Chloride Bp Ddcart‐Cd19 More therapies…

    Learn about Your Condition

    Hepatic cirrhosis Bronchiolitis Anal cancer stage II Pustular psoriasis Aortic valve stenosis Breast cancer female Transplantation complication Factor IX deficiency Uveal melanoma Endometriosis Ichthyosis Oedema peripheral Diabetic retinopathy Mantle cell lymphoma recurrent Menopause More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Mannitol and Normal Saline for Patients with End-Stage Renal Disease Undergoing Kidney Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • End stage renal disease
    • Renal transplant
    Investigated Drugs:
    • Mannitol
    Finland

  • Study of Ifinatamab Deruxtecan and Pembrolizumab, With or Without Chemotherapy, for Patients With Untreated Advanced Esophageal Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Ifinatamab Deruxtecan
    • Sacituzumab Tirumotecan
    • Buclizine Hydrochloride
    Czechia France Germany Italy Norway

  • Study Comparing Duvelisib with Gemcitabine or Bendamustine for Patients with Relapsed or Resistant T Cell Lymphoma Originating from T Follicular Helper Cells

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • DUVELISIB
    • Bendamustine Hydrochloride
    • Gemcitabine Hydrochloride
    Belgium Czechia Denmark France Germany Italy +3

  • Study on the Safety and Effects of BMS-986507 with Pembrolizumab and Osimertinib Mesylate in Adults with Advanced Solid Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • OSIMERTINIB MESYLATE
    • Pembrolizumab
    France Italy The Netherlands Spain

  • Study of ABBV-400 and Budigalimab for Adults with Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Budigalimab
    • Carboplatin
    • Cisplatin
    Belgium France Germany Italy Poland Romania +1

  • Title: Evaluation of lorazepam, pregabalin, and olanzapine in treating agitated behavior in dementia patients who did not respond to standard treatments

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dementia
    Investigated Drugs:
    • Lorazepam
    • Pregabalin
    • Fluoxetine Hydrochloride
    The Netherlands
Previous Page
1 … 233 234 235 236 237 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!